Exercise Now Officially Part of Colon Cancer Treatment: A Paradigm Shift in Oncology
For decades, exercise has been relegated to a supportive role in cancer care – something to manage symptoms or improve quality of life during treatment. Now, a landmark shift is underway. The European Society for Medical Oncology (ESMO) has formally recognized tailored exercise as an integral part of the standard of care for patients undergoing treatment for stages 2 and 3 colon cancer.
The CO21 Challenge: Proof Positive
This groundbreaking change is rooted in the Canadian Cancer Trials Group CO21 Challenge, a 17-year study that definitively demonstrated the power of physical activity to improve cancer survival. The trial involved 889 patients with Stage 2 or 3 colon cancer who had completed chemotherapy. Participants were divided into two groups: one receiving standard health information and the other engaging in a structured exercise program – 2.5 hours of moderate weekly exercise – guided by physiotherapists or kinesiologists over three years.
The results were compelling. Those in the exercise group experienced a 37% lower risk of death and a 28% lower risk of cancer recurrence or the development of new cancers. This isn’t merely symptom management; it’s a tangible impact on survival rates.
From Quality of Life to Essential Treatment
“As far as we know, this is the first time that a non-medical intervention has been included in a treatment flow diagram by any clinical oncology group that provides practice guidelines,” explains Kerry Courneya, professor and Canada Research Chair in Physical Activity and Cancer at the University of Alberta. This signifies a fundamental shift in how oncology teams approach colon cancer treatment.
What Does This Mean for Patients?
The ESMO guidelines now explicitly recommend that eligible patients participate in organized exercise programs. The guidelines also utilize a standardized scoring system to highlight the strength of the evidence supporting exercise interventions. This isn’t a vague suggestion; it’s a call to action for healthcare professionals to actively discuss exercise as a treatment option with their patients.
Every patient diagnosed with Stage 2 or 3 colon cancer should be informed about the vital role exercise can play in their treatment journey and, ideally, be connected with a structured program to support their efforts.
Beyond Colon Cancer: The Potential for Wider Application
While the initial guidelines focus on colon cancer, the implications extend far beyond. Researchers are optimistic that similar recommendations will emerge for other cancer types. The underlying principle – that physical activity can modulate the body’s response to cancer treatment and improve outcomes – is applicable across a broad spectrum of malignancies.
The University of Alberta’s Department of Medical Oncology, in collaboration with the Cross Cancer Institute, is actively involved in research exploring the benefits of exercise for various cancers, including prostate cancer.
Future Trends: Personalized Exercise Prescriptions
The future of exercise oncology lies in personalization. Rather than a one-size-fits-all approach, treatment plans will increasingly incorporate individualized exercise prescriptions tailored to a patient’s specific cancer type, stage, treatment regimen, and overall health status. This will require close collaboration between oncologists, physiotherapists, kinesiologists, and other healthcare professionals.
Expect to notice more sophisticated monitoring tools – wearable sensors, activity trackers, and digital health platforms – used to track patient progress and adjust exercise programs accordingly. The integration of artificial intelligence and machine learning could further refine these personalized prescriptions, optimizing exercise interventions for maximum benefit.
Did you know?
Implementation of Enhanced Recovery After Surgery (ERAS) protocols, including exercise components, has already shown improvements in clinical outcomes for colorectal cancer patients in Alberta, as demonstrated in a 2016 cost impact analysis.
FAQ
Q: What type of exercise is recommended?
A: Moderate-intensity exercise, such as brisk walking, cycling, or swimming, is generally recommended. A structured program guided by a qualified professional is ideal.
Q: Is exercise safe during chemotherapy?
A: In most cases, yes. However, it’s crucial to discuss your exercise plan with your oncologist to ensure it’s appropriate for your individual situation.
Q: How much exercise is enough?
A: The CO21 Challenge utilized 2.5 hours of moderate weekly exercise, but the optimal amount may vary. Start slowly and gradually increase intensity and duration as tolerated.
Q: Where can I find a qualified exercise professional?
A: Your oncologist or cancer care team can provide referrals to physiotherapists or kinesiologists specializing in cancer rehabilitation.
Pro Tip: Don’t wait until you’re feeling your worst to start exercising. Incorporate physical activity into your routine as early as possible in your cancer journey.
Want to learn more about the latest advancements in cancer care? Explore ESMO’s webinar series on colorectal cancer.
Share your thoughts! How do you think this change in guidelines will impact cancer care? Exit a comment below.
